For how we live.
A final order published 9 October classifies systems that let people collect their own specimens for non-viral STI testing as class II, moving them out of the automatic class III that demands premarket approval.
About 7.5% of sexually active women in Britain reported pain lasting three months or more, a national survey found. The usual causes — dryness, vulval pain, infection, endometriosis — are treatable.
No. A controlled study found orgasm did not change testosterone, and in two large cohorts more frequent ejaculation tracked with slightly lower — not higher — prostate cancer risk.
The TRAVERSE trial cleared its cardiovascular safety in 5,246 high-risk men; the Testosterone Trials found a real but moderate sexual-function benefit. Guidelines reserve it for genuine, twice-confirmed deficiency.
HPV drove 71.7% of US oropharyngeal cancers in the most recent period studied, and incidence in men rose 2.7% a year through 2017. Vaccination cuts the oral infections behind them.
Consistent condom use cuts HIV transmission by about 80% and sharply reduces genital HPV, but offers only about 30% protection against genital herpes. The gap is about how each infection spreads.
A network meta-analysis of 118 trials and 31,195 men found every oral PDE5 inhibitor beat placebo, with tadalafil ranked most effective. Guidelines make the tablets, after a health check, the first-line choice.
A study of 3,932 athletes found cyclists had no worse erectile or urinary function than swimmers and runners. But heavy saddle time is tied to genital numbness, and men logging 5+ hours a week showed lower sperm counts.
Taken as prescribed, oral PrEP cuts the risk of getting HIV from sex by about 99%, the CDC says. But randomised trials measured 44% to 86% — because the protection depends almost entirely on taking it.
Pulling out is better than no method but among the least reliable in common use: US data put its first-year failure at 20%. Pre-ejaculatory fluid carried motile sperm in a substantial minority of men studied.
Testosterone raises desire mostly in men whose levels are genuinely low, and the effect is modest. In the largest trial, the size of the hormone rise, not a threshold, tracked with benefit.
One drug, dapoxetine, is purpose-approved for it, and not in the US. An umbrella review of 65 trials found the SSRIs and anaesthetics that lengthen latency rest on weak evidence.
The only FDA-approved drug for the penile-curvature disorder straightens the average man's bend only modestly more than placebo. Surgery is more definitive, and most oral remedies are unsupported.
US guidelines recommend routine chlamydia and gonorrhea screening for sexually active women under 25 and older women at higher risk. Self-collected swabs match clinician-collected ones closely.
Most women have a recurrence within a year of standard treatment. A 2025 trial stopped early once treating a woman alone proved inferior to treating her and her male partner together.
Years of observational data suggested 4CMenB cut gonorrhea risk by a third or more. A placebo-controlled trial in 654 people at high risk found essentially no effect at all.
A 23-year genetic-network analysis of 5,094 cases identified 107 molecular super-spreaders, mostly men aged 50-69, with 94.4% living within 2 km of major transport routes.
Rated against other symptom-management strategies women already use, masturbation scored among the highest for relieving mood changes and sleep disturbance. Nearly half said they'd try it if a doctor suggested it.
Zoliflodacin is the first antibiotic developed solely for gonorrhoea in decades, and a non-profit holds the rights to register it across most of the world.
New EGASP surveillance data released for World AMR Awareness Week show cefixime resistance up from 1.7% to 11% and ciprofloxacin resistance at 95% across 12 reporting countries.